Skystar Bio-Pharmaceutical Co. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2009
2010
2011
2012
2013
Cash & Short Term Investments
11,699.40
5,887.80
7,049.00
11,321.80
8,142.30
Total Accounts Receivable
4,873.90
14,576.70
4,864.00
11,837.00
12,174.40
Inventories
4,074.60
7,202.20
44,078.10
46,400.90
66,964.70
Other Current Assets
11,900.30
17,074.00
2,913.10
2,092.50
1,333.70
Total Current Assets
32,548.30
44,740.80
58,904.20
71,652.30
88,615.10
Net Property, Plant & Equipment
18,218.20
24,203.80
38,413.60
38,248.10
41,814.90
Intangible Assets
1,860.20
6,043.90
5,674.20
5,319.80
5,237.30
Other Assets
7,980.30
6,260.60
884.60
539.20
556.20
Total Assets
60,606.90
81,249.10
103,876.60
115,759.30
136,223.40
ST Debt & Current Portion LT Debt
330.10
3,025.90
7,422.60
5,242.50
10,640.50
Accounts Payable
810.00
472.80
1,047.10
4,017.50
3,303.50
Income Tax Payable
104.30
432.70
160.10
279.70
662.80
Other Current Liabilities
2,811.10
3,422.20
6,707.10
7,666.20
10,359.00
Total Current Liabilities
4,055.40
7,353.60
15,336.90
17,205.90
24,965.90
Long-Term Debt
-
-
-
1,269.60
-
Other Liabilities
1,538.70
1,419.60
43.40
5.60
62.40
Total Liabilities
5,594.10
8,773.30
15,380.30
18,481.10
25,028.30
Common Equity (Total)
53,912.60
71,489.80
88,102.80
96,214.90
110,393.00
Total Shareholders' Equity
53,912.60
71,489.80
88,102.80
96,214.90
110,393.00
Total Equity
53,912.60
71,489.80
88,102.80
96,214.90
110,393.00
Liabilities & Shareholders' Equity
60,606.90
81,249.10
103,876.60
115,759.30
136,223.40
Non-Equity Reserves
1,100.30
986.10
393.50
1,063.30
802.10
About Skystar Bio-Pharmaceutical
View Profile
